Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
20.27
+0.09 (0.45%)
Aug 4, 2026, 3:04 PM CST
SHE:002880 Market Cap
SHE:002880 has a market cap or net worth of 4.58 billion as of August 4, 2026. Its market cap has decreased by -31.62% in one year.
Market Cap
4.58B
Enterprise Value
5.35B
Revenue
1.26B
Ranking
n/a
PE Ratio
19.60
Stock Price
20.27
ChartMarket Cap Chart
Since June 16, 2017, SHE:002880's market cap has increased from 3.91B to 4.58B, an increase of 17.20%. That is a compound annual growth rate of 1.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.60B | -20.51% |
| Dec 31, 2025 | 5.78B | -5.59% |
| Dec 31, 2024 | 6.13B | -23.11% |
| Dec 29, 2023 | 7.97B | 10.16% |
| Dec 30, 2022 | 7.23B | -0.90% |
| Dec 31, 2021 | 7.30B | -6.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 4.87B |
| PharmaResources (Shanghai) | 4.78B |
| Suzhou Fengbei Biotech Stock | 4.74B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.73B |
| Beijing Konruns Pharmaceutical | 4.70B |
| ChemPartner PharmaTech | 4.54B |
| Xiangxue Pharmaceutical | 4.46B |
| Anhui Huaheng Biotechnology | 4.29B |